FitARise: Making Exercise Advice and Referrals a Routine Part of Cancer Care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This implementation study tests the FitARise protocol, which follows ASCM recommendations for exercise assessment, advice, and referral in routine cancer care. The study compares an implementation-strategy approach (audit, feedback, facilitation, and adaptable workflow) to a control condition where the protocol is available but not actively implemented. The primary outcome is the reach: the percentage of eligible patients who are assessed, advised, and referred based on BMI and treatment status. Qualitative methods will explore how clinicians and staff experience the implementation. Eligible participants are adults with cancer, BMI ≥ 23, within five years post-treatment, and literate in Chinese or English; eligible clinicians include oncologists at participating sites in Hong Kong.

Why it matters

Who can join: the full rules

Inclusion Criteria (Cancer patients):

* All cancer patients with BMI score\>=23;
* Have completed cancer treatment within the past five years;
* At least 18 years old;
* Are literate in Chinese or English;
* Are eligible to attend the intervention program.

Exclusion Criteria (Cancer patients):

* Patients who have completed cancer treatments for more than five years;
* Non-Cantonese, non-Mandarin, non-English speakers.

Inclusion Criteria (Clinical staff):

\- All clinical, medical or surgical oncologists at the study units during the study period.

Exclusion Criteria (Clinical staff):

\- No exclusion criterial for staff.

Where it's running

• KWH Department of Surgery
  Hong Kong, Hong Kong Recruiting
• PMH Department of Oncology
  Hong Kong, Hong Kong Recruiting
• PYEH Department of Clinical Oncology
  Hong Kong, Hong Kong Recruiting
• QMH Department of Clinical Oncology
  Hong Kong, Hong Kong Recruiting
• QMH Department of Obstetrics and Gynaecology
  Hong Kong, Hong Kong Recruiting
• QMH Department of Surgery
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Wendy Lam, PhD — The University of Hong Kong
• Study coordinator: Wendy Lam, PhD
• Email: wwtlam@hku.hk
• Phone: +852 39179878

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.